Basic epidemiology and immunopathology of RSV in children

Paediatric Respiratory Reviews

Volumn 1, Issue 3, 2000, Pages 210-214

  Handforth, J ^a   Friedland, J S ^b   Sharland, M ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Bronchiolitis; Chemokines; Epidemiology; Immunopathology; Respiratory syncytial virus; T cell

Indexed keywords

CHILD; DISEASE TRANSMISSION; HUMAN; IMMUNOLOGY; INCIDENCE; INFANT; NEWBORN; PRESCHOOL CHILD; PREVALENCE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK FACTOR; VIRUS INFECTION;

CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; PREVALENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS;

EID: 2342633521     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1054/prrv.2000.0050     Document Type: Conference Paper

References (15)

1. Channock R, Finberg L. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Am J Hyg 1957; 66: 291-300.
2. Prober CG, Sullender WM. Advances in prevention of respiratory syncytial virus infections. J Pediatr 1999; 135: 546-558.
3. Sullender WM, Mufson MA, Prince GA, Anderson LJ, Wertz GW Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. J Infect Dis 1998; 178: 925-932.
4. Hall CB. Respiratory syncytial virus: a continuing culprit and conundrum. J Pediatr 1999; 135: s2-s7.
5. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD (eds). Textbook of Pediatric Infectious Diseases. Philadelphia: W.B. Saunders 1998; 2084-2111.
6. De Boeck K. Respiratory syncytial virus bronchiolitis: clinical aspects and epidemiology. Monaldi Arch Chest Dis 1996; 51: 3, 210-213.
7. Levy BT, Graber MA. Respiratory syncytial virus infection in infants and young children. J Fam Pract 1997; 45: 6, 473-481.
8. Darville T, Yamauchi T. Respiratory syncytial virus. Paediatr Rev 1998; 19: 56-61.
9. Simoes EAF. Respiratory syncytial virus infection. Lancet 1999; 354: 847-852.
10. Wyde PR. Respiratory syncytial virus (RSV) disease and prospects for its control. Antiviral Res 1998; 39: 63-79.
11. Yamazaki H, Tsutsumi H, Matsuda K, Nagai K, Ogra PL, Chiba S. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J Gen Virol 1994; 75: 2115-2119.
12. Welliver RC. Immunologic mechanisms of virus-induced wheezing and asthma. J Pediatr 1999; 135: s14-s20.
13. Cannon MJ, Openshaw PJM, Askonas BA. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988; 168: 1163-1168.
14. Graham BS. Immunological determinants of disease caused by respiratory syncytial virus. Trends in Microbiol 1996; 4: 290-294.
15. Thomas LH, Friedland JS, Sharland M, Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-κB nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of κBα. J Immunol 1998; 161: 1007-1016.